McKesson | MCK - Cost Of Sales

Stock Price
870.66
Daily Change
14.04 1.64%
Monthly
-7.59%
Yearly
29.61%
Q2 Forecast
857.66

McKesson reported $102.47B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Acadia Healthcare USD 30.41M 1.88M Sep/2025
Align Technology USD 363.97M 7.48M Dec/2025
Cardinal Health USD 63.36B 1.57B Dec/2025
Centene USD 47.59B 831M Dec/2025
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Cigna USD 63.37B 1.93B Sep/2025
Community Health Systems USD 555M 13M Dec/2025
Computer Programs Systems USD 52.17M 9.8M Dec/2025
CVS Health USD 92.13B 3.06B Dec/2025
DaVita Healthcare Partners USD 2.6B 263.46M Dec/2025
Dentsply International USD 518M 55M Dec/2025
eHealth USD 58.41M 7.45M Sep/2024
Elevance Health USD 38.07B 75M Dec/2025
Encompass Health USD 150.9M 3.9M Dec/2025
HCA USD 3.89B 7.26B Dec/2025
Henry Schein USD 2.44B 62M Dec/2025
Humana USD 26.54B 1.15B Mar/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
J&J USD 7.97B 689M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
McKesson USD 102.47B 2.86B Dec/2025
Molina Healthcare USD 10.18B 91M Dec/2025
Owens Minor USD 436.92M 32.62M Dec/2025
Quest Diagnostics USD 1.93B 27M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tenet Healthcare USD 1.24B 1.89B Dec/2025
UnitedHealth USD 92.52B 920M Sep/2025
Universal Health Services USD 2.49B 52.74M Sep/2025
Veradigm USD 124.74M 56.25M Dec/2022